Prof. Dr. med. Julia Bohlius, MD MScPH

Head of Department

Organisational Entity


Julia Bohlius is the Head of Department for Education and Training and the Swiss Tropical and Public Health Institute (Swiss TPH) and Professor of Cancer Epidemiology at the University of Basel. She is a trained physician and holds an MSc in Public Health from the London School of Hygience and Tropical Medicine, UK. Julia has clinical research experience from the Univeristy of Cologne, Germany, as well as Public Health and Epidemiology from the Univeristy of Bern, Institute of Social and Preventive Medicine, where she led the Cancer Research Group for several years. Her research, teaching and training interests span from assessing the burden of cancer in populations living with HIV at global scale to improving quality and access to health care for women at high risk for cervical cancer to critically assess and synthesize the evidence and clinical guideline development for interventions in oncology. For her research she was awarded with a Ambizione-PROSPER grant of the Swiss National Science Foundation and the Robert Wenner Prize of the Swiss Cancer League.

Davidović M et al. Facility-based indicators to manage and scale up cervical cancer prevention and care services for women living with hiv in sub-Saharan Africa: a three-round online Delphi consensus method. J Acquir Immune Defic Syndr. 2024;95(2):170-178. DOI: 10.1097/qai.0000000000003343

Dhokotera T.G et al. Gynaecologic and breast cancers in women living with HIV in South Africa: a record linkage study. Int J Cancer. 2024;154(2):284-296. DOI: 10.1002/ijc.34712

Engels E.A et al. State of the science and future directions for research on HIV and cancer: summary of a joint workshop sponsored by IARC and NCI. Int J Cancer. 2024;154(4):596-606. DOI: 10.1002/ijc.34727

Chipanta D et al. Socioeconomic inequalities in cervical precancer screening among women in Ethiopia, Malawi, Rwanda, Tanzania, Zambia and Zimbabwe: analysis of population-based HIV impact assessment surveys. BMJ Open. 2023;13(6):e067948. DOI: 10.1136/bmjopen-2022-067948

Metekoua C et al. Decreasing incidence of conjunctival squamous cell carcinoma in people with HIV in South Africa. J Natl Cancer Inst. 2023;115(10):1213-1219. DOI: 10.1093/jnci/djad119

Ruffieux Y et al. Age and cancer incidence in 5.2 million people with HIV: the South African HIV Cancer Match study. Clin Infect Dis. 2023;76(8):1440-1448. DOI: 10.1093/cid/ciac925

Trunk G, Davidović M, Bohlius J. Non-specific effects of Bacillus Calmette-Guérin: a systematic review and meta-analysis of randomized controlled trials. Vaccines (Basel). 2023;11:121. DOI: 10.3390/vaccines11010121

Asangbeh-Kerman S.L et al. Cervical cancer prevention in countries with the highest HIV prevalence: a review of policies. BMC Public Health. 2022;22:1530. DOI: 10.1186/s12889-022-13827-0

Dhokotera T et al. Cervical cancer in women living in South Africa: a record linkage study of the National Health Laboratory Service and the National Cancer Registry. Ecancermedicalscience. 2022;16:1348. DOI: 10.3332/ECANCER.2022.1348

Muchengeti M et al. Cohort profile: the South African HIV Cancer Match (SAM) study, a national population-based cohort. BMJ Open. 2022;12:2:e0534. DOI: 10.1136/bmjopen-2021-053